Mitochondrial Dysfunction and Oxidative Damage in parkin-deficient Mice
Open accessThe DOI matches its Crossref record; 67 of the 67 references it cites were found in a registry or an index.
Abstract
Loss-of-function mutations in parkin are the predominant cause of familial Parkinson's disease. We previously reported that parkin-/- mice exhibit nigrostriatal deficits in the absence of nigral degeneration. Parkin has been shown to function as an E3 ubiquitin ligase. Loss of parkin function, therefore, has been hypothesized to cause nigral degeneration via an aberrant accumulation of its substrates. Here we employed a proteomic approach to determine whether loss of parkin function results in alterations in abundance and/or modification of proteins in the ventral midbrain of parkin-/- mice. Two-dimensional gel electrophoresis followed by mass spectrometry revealed decreased abundance of a number of proteins involved in mitochondrial function or oxidative stress. Consistent with reductions in several subunits of complexes I and IV, functional assays showed reductions in respiratory capacity of striatal mitochondria isolated from parkin-/- mice. Electron microscopic analysis revealed no gross morphological abnormalities in striatal mitochondria of parkin-/- mice. In addition, parkin-/- mice showed a delayed rate of weight gain, suggesting broader metabolic abnormalities. Accompanying these deficits in mitochondrial function, parkin-/- mice also exhibited decreased levels of proteins involved in protection from oxidative stress. Consistent with these findings, parkin-/- mice showed decreased serum antioxidant capacity and increased protein and lipid peroxidation. The combination of proteomic, genetic, and physiological analyses reveal an essential role for parkin in the regulation of mitochondrial function and provide the first direct evidence of mitochondrial dysfunction and oxidative damage in the absence of nigral degeneration in a genetic mouse model of Parkinson's disease.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Importantly, mitophagy deficiency favored by ablation of Prkn (Palacino et al, 2004; Pickrell et al, 2015) or Pink1 (Gautier et al, 2008) sensitizes mice to oxidative stress, while worsening neural damage when combined with mitochondrial dysfunction (mitochondrial DNA [mtDNA] mutator‐prkn/parkin‐KO mice) (Pickrell et al, 2015).”
From Autophagy in major human diseases (2021) · cites this paper as Palacino et al, 2004
In the citing paper
“Both Pink1 and Parkin knockout mice exhibit increased ROS levels and mitochondrial dysfunction (43, 44), and persistent increased ROS is one of the important factors in accelerating cellular senescence (42, 45).”
From Impaired mitophagy leads to cigarette smoke stress‐induced cellular senescence: implications for chronic obstructive pulmonary disease (2015) · cites this paper as [43]
Citations
Cites
Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease
Polymeropoulos, M. H., Lavedan, C., Leroy, E., Ide, S. E., Dehejia, A., Dutra, A., Pike, B., Root, H., Rubenstein, J., Boyer, R., et al. (1997) · Science · doi:10.1126/science.276.5321.2045 · Cited by 8,240
Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism
Kitada, T., Asakawa, S., Hattori, N., Matsumine, H., Yamamura, Y., Minoshima, S., Yokochi, M., Mizuno, Y., & Shimizu, N. (1998) · Nature · doi:10.1038/33416 · Cited by 5,227
Chronic Parkinsonism in Humans Due to a Product of Meperidine-Analog Synthesis
Langston, J. W., Ballard, P., Tetrud, J. W., & Irwin, I. (1983) · Science · doi:10.1126/science.6823561 · Cited by 4,914
α-Synuclein Locus Triplication Causes Parkinson's Disease
Singleton, A. B., Farrer, M., Johnson, J., Singleton, A., Hague, S., Kachergus, J., Hulihan, M., Peuralinna, T., Dutra, A., Nussbaum, R., et al. (2003) · Science · doi:10.1126/science.1090278 · Cited by 4,383
The new mutation, E46K, of α‐synuclein causes parkinson and Lewy body dementia
Zarranz, J. J., Alegre, J., Gómez‐Esteban, J. C., Lezcano, E., Ros, R., Ampuero, I., Vidal, L., Hoenicka, J., Rodriguez, O., Atarés, B., et al. (2004) · Annals of Neurology · doi:10.1002/ana.10795 · Cited by 2,737
Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase
Shimura, H., Hattori, N., Kubo, S.-I., Mizuno, Y., Asakawa, S., Minoshima, S., Shimizu, N., Iwai, K., Chiba, T., Tanaka, K., et al. (2000) · Nature Genetics · doi:10.1038/77060 · Cited by 2,024
Molecular Pathways of Neurodegeneration in Parkinson's Disease
Dawson, T. M., & Dawson, V. L. (2003) · Science · doi:10.1126/science.1087753 · Cited by 1,663
ETIOLOGY AND PATHOGENESIS OF PARKINSON'S DISEASE
Olanow, C. W., & Tatton, W. G. (1999) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.22.1.123 · Cited by 1,396
Mitochondrial pathology and apoptotic muscle degeneration in Drosophila parkin mutants
Greene, J. C., Whitworth, A. J., Kuo, I., Andrews, L. A., Feany, M. B., & Pallanck, L. J. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0737556100 · Cited by 1,203
Immunohistochemical detection of 4-hydroxynonenal protein adducts in Parkinson disease.
Yoritaka, A., Hattori, N., Uchida, K., Tanaka, M., Stadtman, E. R., & Mizuno, Y. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.7.2696 · Cited by 981
Parkin-deficient Mice Exhibit Nigrostriatal Deficits but Not Loss of Dopaminergic Neurons
Goldberg, M. S., Fleming, S. M., Palacino, J. J., Cepeda, C., Lam, H. A., Bhatnagar, A., Meloni, E. G., Wu, N., Ackerson, L. C., Klapstein, G. J., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m308947200 · Cited by 913
Self-citationEssential role for the peroxiredoxin Prdx1 in erythrocyte antioxidant defence and tumour suppression
Neumann, C. A., Krause, D. S., Carman, C. V., Das, S., Dubey, D. P., Abraham, J. L., Bronson, R. T., Fujiwara, Y., Orkin, S. H., & Van Etten, R. A. (2003) · Nature · doi:10.1038/nature01819 · Cited by 801
Xu, J., Kao, S.-Y., Lee, F. J. S., Song, W., Jin, L.-W., & Yankner, B. A. (2002) · Nature Medicine · doi:10.1038/nm0602-600 · Cited by 757
α-Synuclein Promotes Mitochondrial Deficit and Oxidative Stress
Hsu, L. J., Sagara, Y., Arroyo, A., Rockenstein, E., Sisk, A., Mallory, M., Wong, J., Takenouchi, T., Hashimoto, M., & Masliah, E. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64553-1 · Cited by 714
Sherer, T. B., Betarbet, R., Stout, A. K., Lund, S., Baptista, M., Panov, A. V., Cookson, M. R., & Greenamyre, J. T. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-16-07006.2002 · Cited by 581
Alam, Z. I., Daniel, S. E., Lees, A. J., Marsden, D. C., Jenner, P., & Halliwell, B. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.69031326.x · Cited by 547
Role of oxidation in the neurotoxic effects of intrastriatal dopamine injections.
Hastings, T. G., Lewis, D. A., & Zigmond, M. J. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.5.1956 · Cited by 547
Mitochondria, Oxidative Damage, and Inflammation in Parkinson's Disease
BEAL, M. F. (2003) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2003.tb07470.x · Cited by 523
MacMillan-Crow, L. A., Crow, J. P., & Thompson, J. A. (1998) · Biochemistry · doi:10.1021/bi971894b · Cited by 512
Parkin gene inactivation alters behaviour and dopamine neurotransmission in the mouse
Itier, J.-M. (2003) · Human Molecular Genetics · doi:10.1093/hmg/ddg239 · Cited by 508
Lewy bodies and parkinsonism in families with parkin mutations
Farrer, M., Chan, P., Chen, R., Tan, L., Lincoln, S., Hernandez, D., Forno, L., Gwinn‐Hardy, K., Petrucelli, L., Hussey, J., et al. (2001) · Annals of Neurology · doi:10.1002/ana.1132 · Cited by 485
(2002) · doi:10.1016/s0896-6273(02)01125-x · Cited by 473
Yang, K.-S., Kang, S. W., Woo, H. A., Hwang, S. C., Chae, H. Z., Kim, K., & Rhee, S. G. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m206626200 · Cited by 458
Peroxiredoxin II is essential for sustaining life span of erythrocytes in mice
Lee, T.-H. (2003) · Blood · doi:10.1182/blood-2002-08-2548 · Cited by 420
Oxidative Stress and Genetics in the Pathogenesis of Parkinson's Disease
Zhang, Y., Dawson, V. L., & Dawson, T. M. (2000) · Neurobiology of Disease · doi:10.1006/nbdi.2000.0319 · Cited by 407
Parkin prevents mitochondrial swelling and cytochrome c release in mitochondria-dependent cell death
Darios, F. (2003) · Human Molecular Genetics · doi:10.1093/hmg/12.5.517 · Cited by 403
Staropoli, J. F., McDermott, C., Martinat, C., Schulman, B., Demireva, E., & Abeliovich, A. (2003) · Neuron · doi:10.1016/s0896-6273(03)00084-9 · Cited by 381
Expression of the murine alpha B-crystallin gene is not restricted to the lens.
Dubin, R. A., Wawrousek, E. F., & Piatigorsky, J. (1989) · Molecular and Cellular Biology · doi:10.1128/mcb.9.3.1083 · Cited by 372
Parkin Suppresses Dopaminergic Neuron-Selective Neurotoxicity Induced by Pael-R in Drosophila
Yang, Y., Nishimura, I., Imai, Y., Takahashi, R., & Lu, B. (2003) · Neuron · doi:10.1016/s0896-6273(03)00143-0 · Cited by 364
Genetic analysis of the mouse brain proteome
Klose, J., Nock, C., Herrmann, M., Stühler, K., Marcus, K., Blüggel, M., Krause, E., Schalkwyk, L. C., Rastan, S., Brown, S. D. M., et al. (2002) · Nature Genetics · doi:10.1038/ng861 · Cited by 327
Self-citationWang, X., Phelan, S. A., Forsman-Semb, K., Taylor, E. F., Petros, C., Brown, A., Lerner, C. P., & Paigen, B. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m302706200 · Cited by 318
Dexter, D. T., Sian, J., Rose, S., Hindmarsh, J. G., Mann, V. M., Cooper, J. M., Wells, F. R., Daniel, S. E., Lees, A. J., Schapira, A. H. V., et al. (1994) · Annals of Neurology · doi:10.1002/ana.410350107 · Cited by 317
Formation and Removal of α-Synuclein Aggregates in Cells Exposed to Mitochondrial Inhibitors
Lee, H.-J., Shin, S. Y., Choi, C., Lee, Y. H., & Lee, S.-J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m105326200 · Cited by 291
Haft, C. R., Sierra, M. D. L. L., Bafford, R., Lesniak, M. A., Barr, V. A., & Taylor, S. I. (2000) · Molecular Biology of the Cell · doi:10.1091/mbc.11.12.4105 · Cited by 281
. Chun, H. S., Gibson, G. E., DeGiorgio, L. A., Zhang, H., Kidd, V. J., & Son, J. H. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00096.x · Cited by 256
Viner, R. I., Williams, T. D., & Schöneich, C. (1999) · Biochemistry · doi:10.1021/bi9909445 · Cited by 252
RhoA/ROCK regulation of neuritogenesis via profilin IIa–mediated control of actin stability
Da Silva, J. S., Medina, M., Zuliani, C., Di Nardo, A., Witke, W., & Dotti, C. G. (2003) · The Journal of Cell Biology · doi:10.1083/jcb.200304021 · Cited by 249
Mitochondrial dysfunction in Parkinson's disease
Greenamyre, J. T., MacKenzie, G., Peng, T.-I., & Stephans, S. E. (1999) · Biochemical Society Symposia · doi:10.1042/bss0660085 · Cited by 248
Corti, O. (2003) · Human Molecular Genetics · doi:10.1093/hmg/ddg159 · Cited by 244
Münch, G., Lüth, H. J., Wong, A., Arendt, T., Hirsch, E., Ravid, R., & Riederer, P. (2000) · Journal of Chemical Neuroanatomy · doi:10.1016/s0891-0618(00)00096-x · Cited by 231
Heterozygosity for a mutation in the parkin gene leads to later onset Parkinson disease
Foroud, T., Uniacke, S. K., Liu, L., Pankratz, N., Rudolph, A., Halter, C., Shults, C., Marder, K., Conneally, P. M., Nichols, W. C., et al. (2003) · Neurology · doi:10.1212/01.wnl.0000049470.00180.07 · Cited by 214
Hayashi, S., Wakabayashi, K., Ishikawa, A., Nagai, H., Saito, M., Maruyama, M., Takahashi, T., Ozawa, T., Tsuji, S., & Takahashi, H. (2000) · Movement Disorders · doi:10.1002/1531-8257(200009)15:5<884::aid-mds1019>3.0.co;2-8 · Cited by 212
Mitochondrial dysfunction in neurodegenerative disorders
Schapira, A. H. V. (1998) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/s0005-2728(98)00115-7 · Cited by 209
The roles of heterogeneous nuclear ribonucleoproteins (hnRNP) in RNA metabolism
Weighardt, F., Biamonti, G., & Riva, S. (1996) · BioEssays · doi:10.1002/bies.950180910 · Cited by 200
Hyun, D.-H., Lee, M., Hattori, N., Kubo, S.-I., Mizuno, Y., Halliwell, B., & Jenner, P. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200666200 · Cited by 172
Castellani, R. J., Perry, G., Siedlak, S. L., Nunomura, A., Shimohama, S., Zhang, J., Montine, T., Sayre, L. M., & Smith, M. A. (2002) · Neuroscience Letters · doi:10.1016/s0304-3940(01)02514-9 · Cited by 169
Inactivation of Parkin by Oxidative Stress and C-terminal Truncations
Winklhofer, K. F., Henn, I. H., Kay-Jackson, P. C., Heller, U., & Tatzelt, J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m306769200 · Cited by 143
Serra, J. A., Domínguez, R. O., de Lustig, E. S., Guareschi, E. M., Famulari, A. L., Bartolomé, E. L., & Marschoff, E. (2001) · Journal of Neural Transmission · doi:10.1007/s007020170003 · Cited by 132
Endometrial Pinopodes and Uterine Receptivity
NIKAS, G., & MAKRIGIANNAKIS, A. (2003) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1290.042 · Cited by 113
Sousa, S. C., Maciel, E. N., Vercesi, A. E., & Castilho, R. F. (2003) · FEBS Letters · doi:10.1016/s0014-5793(03)00421-6 · Cited by 110
Influence of methylglyoxal on antioxidant enzymes and oxidative damage
Choudhary, D., Chandra, D., & Kale, R. K. (1997) · Toxicology Letters · doi:10.1016/s0378-4274(97)00087-8 · Cited by 97
Singer, T. P., Ramsay, R. R., McKeown, K., Trevor, A., & Castagnoli, N. E. (1988) · Toxicology · doi:10.1016/0300-483x(88)90169-2 · Cited by 96
Morel, P., Tallineau, C., Pontcharraud, R., Piriou, A., & Huguet, F. (1998) · Neurochemistry International · doi:10.1016/s0197-0186(98)00062-x · Cited by 95
Lasp-1, a Novel Type of Actin-Binding Protein Accumulating in Cell Membrane Extensions
Schreiber, V., Moog-Lutz, C., Régnier, C. H., Chenard, M.-P., Boeuf, H., Vonesch, J.-L., Tomasetto, C., & Rio, M.-C. (1998) · Molecular Medicine · doi:10.1007/bf03401929 · Cited by 94
Oxidative stress in rat cortical neurons and astrocytes induced by paraquatin vitro
Schmuck, G., Röhrdanz, E., Tran-Thi, Q.-H., Kahl, R., & Schlüter, G. (2002) · Neurotoxicity Research · doi:10.1080/10298420290007574 · Cited by 89
Chronic reduction in complex I function alters calcium signaling in SH-SY5Y neuroblastoma cells
Sherer, T., Trimmer, P. A., Borland, K., Parks, J. K., Bennett, J. P., & Tuttle, J. B. (2001) · Brain Research · doi:10.1016/s0006-8993(00)03203-0 · Cited by 76
Morikawa, N., Nakagawa‐Hattori, Y., & Mizuno, Y. (1996) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1996.66031174.x · Cited by 74
Role of Mitochondria in Parkinson Disease
Kösel, S., Hofhaus, G., Maassen, A., Vieregge, P., & Graeber, M. B. (1999) · Biological Chemistry · doi:10.1515/bc.1999.106 · Cited by 70
Gluck, M., Ehrhart, J., Jayatilleke, E., & Zeevalk, G. D. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.00938.x · Cited by 61
Paraquat and Parkinson's disease
Koller, W. C. (1986) · Neurology · doi:10.1212/wnl.36.8.1147-b · Cited by 57
Genetics of Parkinsonism: a review
VAUGHAN, J. R., DAVIS, M. B., & WOOD, N. W. (2001) · Annals of Human Genetics · doi:10.1046/j.1469-1809.2001.6520111.x · Cited by 57
α-Synuclein expression in HEK293 cells enhances the mitochondrial sensitivity to rotenone
Orth, M., Tabrizi, S. J., Schapira, A. H. V., & Cooper, J. A. D. (2003) · Neuroscience Letters · doi:10.1016/s0304-3940(03)00941-8 · Cited by 53
Parkin's Substrates and the Pathways Leading to Neuronal Damage
Cookson, M. (2003) · NeuroMolecular Medicine · doi:10.1385/nmm:3:1:1 · Cited by 52
Fractionated Extraction of Total Tissue Proteins from Mouse and Human for 2-D Electrophoresis
Klose, J. (2003) · Humana Press eBooks · doi:10.1385/1-59259-584-7:67 · Cited by 51
Self-citationGenetics of Parkinsonism: a review.
Vaughan, J. R., Davis, M. B., & Wood, N. W. (2001) · PubMed · doi:10.1017/s0003480001008557 · Cited by 49
Modulation of D1-like dopamine receptor function by aldehydic products of lipid peroxidation
Shin, Y., White, B. H., Uh, M., & Sidhu, A. (2003) · Brain Research · doi:10.1016/s0006-8993(02)04279-8 · Cited by 31
2-Oxoaldehydes, Glyoxalase I and Oxidative Stress
CORDEIRO, C. A., & Freire, A. P. (1996) · Biochemical Society Transactions · doi:10.1042/bst024472s · Cited by 3
Research works printed but not linked: 5
- Jenner, 1996, Neurology, 47, 5161
- Koller, 1986, Neurology, 36
- Darios, 2003, Hum. Mol. Genet., 12, 517, 10.1093/hmg/ddg044 · doi:10.1093/hmg/ddg044 · Paper page
- Klose, 1999, Methods Mol. Biol., 112, 67
- Dubin, 1989, Mol. Cell. Biol., 9, 1083
Cited by
Repertoires of Autophagy in the Pathogenesis of Ocular Diseases
Li, Y.-J., Jiang, Q., Cao, G.-F., Yao, J., & Yan, B. (2015) · Cellular Physiology and Biochemistry · doi:10.1159/000373980 · Cited by 16,304
Mitochondrial Dysfunction and Oxidative Stress in Neurodegenerative Diseases
Lin, M. T., & Beal, M. F. (2006) · Nature · doi:10.1038/nature05292 · Cited by 6,455
Wallace, D. C. (2005) · Annual Review of Genetics · doi:10.1146/annurev.genet.39.110304.095751 · Cited by 3,185
PINK1 Is Selectively Stabilized on Impaired Mitochondria to Activate Parkin
Narendra, D. P., Jin, S. M., Tanaka, A., Suen, D.-F., Gautier, C. A., Shen, J., Cookson, M. R., & Youle, R. J. (2010) · PLoS Biology · doi:10.1371/journal.pbio.1000298 · Cited by 2,944
“in the striatium (which receives projections from dopaminergic neurons) [16,17]; and primary cells from patients with loss-offunction mutations in Parkin or PINK1 have similar abnormalities [18–20].”
BackgroundSelf-citationThe Roles of PINK1, Parkin, and Mitochondrial Fidelity in Parkinson’s Disease
Pickrell, A. M., & Youle, R. J. (2015) · Neuron · doi:10.1016/j.neuron.2014.12.007 · Cited by 2,310
“Aged ParkinKO brains have altered expression of mitochondrial proteins and a reduction in respiratory capacity (Palacino et al., 2004; Periquet et al., 2005; Stichel et al., 2007).”
Background
Metadata
- Authors
- Palacino, J. J., Sagi, D., Goldberg, M. S., Krauss, S., Motz, C., Wacker, M., Klose, J., & Shen, J.
- Affiliations
- Brigham and Women's Hospital (US)
- Beth Israel Deaconess Medical Center (US)
- Charité – Universitätsmedizin Berlin (DE)
- Corresponding author
- Shen, Jie
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2004-04
- Volume
- 279
- Issue
- 18
- Pages
- 18614-18622
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2140647923
- Cited by
- 995
- References
- 66
- Citations by year
- 2026: 7 · 2025: 14 · 2024: 34 · 2023: 29 · 2022: 27 · 2021: 44 · 2020: 51 · 2019: 39 · 2018: 41 · 2017: 32 · 2016: 41 · 2015: 41 · 2014: 42 · 2013: 60 · 2012: 49
- FWCI
- 42.50
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 6031 d)
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- Centers for Disease Control and Prevention
- Topics
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Coenzyme Q10 studies and effects
- Keywords
- Parkin, Parkinson's disease, mitochondrial dysfunction, oxidative stress, E3 ubiquitin ligase, nigrostriatal pathway, complex I, cytochrome c oxidase, respiratory capacity, lipid peroxidation, protein peroxidation, serum antioxidant capacity, metabolic abnormalities
- MeSH terms
- Animals, Antioxidants, Basal Ganglia, Mitochondria, Oxidative Phosphorylation, Parkinson Disease, Protein Processing, Post-Translational, Weight Gain, Reactive Oxygen Species, Mice, Knockout, Oxidative Stress, Cell Respiration, Mitochondrial Proteins, Mitochondrial Diseases, Ubiquitin-Protein Ligases, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.